comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-29 19:57:50 - browse：351

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Syphilis numbers in the United States reach record heights

hotspot

WSS

Ohioans vote in high

Zyn nicotine pouches become unlikely player in latest culture war

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Boston competes with Raleigh

Discs beat pads, tampons for heavy menstrual flow, new study shows

Venture capital firm's plans to take over Akron hospital face hurdles

entertainment

comprehensive

entertainment

Virginia high school admissions case could be legal follow

Sage's campaign to raise awareness of postpartum depression hits a nerve

Duchenne breakthrough therapy leaves behind pioneering families

Bernie Sanders is gearing up to subpoena pharma CEOs

The cancer drug shortage isn’t new — and neither are the solutions

Pancreatic cancer early detection could be helped by AI

Cancer drug shortages should be causing more outrage

CDC launches VaccineFinder tool to locate Covid

Peter Hotez and the public health issue of online harassment

CDC launches VaccineFinder tool to locate Covid

hotspot

The painfully weak evidence on taking collagen to treat arthritis

Hospitals use virtual reality to design more inclusive rooms for kids

How generative AI ratchets up security threats for health systems

How generative AI ratchets up security threats for health systems

Merck, Johnson & Johnson CEOs will testify on high drug prices

Astronauts get first look at the spacecraft that will fly them around the moon

hotspot

hotspot

hotspot

hotspot